Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study (Q34024389)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study |
scientific article |
Statements
1 reference
Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study (English)
1 reference
Sarah H Lisanby
1 reference
James Kimball
1 reference
William M McDonald
1 reference
Philip G Janicak
1 reference
Shirlene M Sampson
1 reference
H Brent Solvason
1 reference
Lauren B Marangell
1 reference
John P O'Reardon
1 reference
Mustafa H Husain
1 reference
William Gilmer
1 reference
Sheila M Dowd
1 reference
Mark A Demitrack
1 reference
Alan F Schatzberg
1 reference
11 August 2010
1 reference
1 reference
Identifiers
1 reference